https://www.selleckchem.com/pr....oducts/dual-specific
No previous systematic review and meta-analysis have comprehensively evaluated the association of asymmetric dimethylarginine (ADMA) level with adverse prognosis in individuals undergoing percutaneous coronary interventions (PCI)/coronary angiography (CAG). The aim of this systematic review and meta-analysis was to assess the predictive value of the elevated ADMA level in individuals undergoing CAG/PCI. Two authors independently searched PubMed and Embase databases (up to 31 October 202 f
Beğen
Yorum Yap
Paylaş
